Article
Structural insights of catalytic mechanism in mutant pyrazinamidase of Mycobacterium tuberculosis.
Journal of biomolecular structure & dynamics - 1 Jun 2021
Junaid Muhammad, Li Cheng-Dong, Li Jiayi, Khan Abbas, Ali Syed Shujait, Jamal Syed Baber, Saud Shah, Ali Arif, Wei Dong-Qing
Abstract excerpt
Pyrazinamidase (PZase) is a member of Fe-dependent amidohydrolases that activates pyrazinamide (PZA) into active pyrazinoic acid (POA). PZA, a nicotinamide analogue, is an essential first-line drug used in Mycobacterium tuberculosis (Mtb) treatment. The active form of PZA, POA, is toxic and potently inhibits the growth of latent Mtb, which makes it possible to shorten the conventional 9-month tuberculosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
